American Vanguard Corporation · Healthcare · Chemicals
As of 2026-06-26, American Vanguard Corporation (AVD) has a 3-month relative strength percentile of 72 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.1%, relative volume 8.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 72, Market Stance is mixed at 47, A/D rating D
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
AVD is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.8% / -34.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
AVD is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional. Top 3 carry $4M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| IWMiShares Russell 2000 ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $766K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AVD Jan avg: 17.52% median: 18.52% win: 75% σ: 18.24% n: 4 2022-04-12 → 2026-05-29 | AVD Feb avg: -8.88% median: -8.43% win: 0% σ: 6.18% n: 4 2022-04-12 → 2026-05-29 | AVD Mar avg: -8.69% median: -4.78% win: 50% σ: 28.73% n: 4 2022-04-12 → 2026-05-29 | AVD Apr avg: -2.76% median: -4.09% win: 20% σ: 11.35% n: 5 2022-04-12 → 2026-05-29 | AVD May avg: -2.72% median: -10.42% win: 40% σ: 17.84% n: 5 2022-04-12 → 2026-05-29 | AVD Jun avg: -6.51% median: -5.24% win: 25% σ: 10.90% n: 4 2022-04-12 → 2026-05-29 (current) | AVD Jul avg: 4.03% median: 2.90% win: 75% σ: 5.82% n: 4 2022-04-12 → 2026-05-29 | AVD Aug avg: -9.70% median: -19.17% win: 25% σ: 34.71% n: 4 2022-04-12 → 2026-05-29 | AVD Sep avg: -7.11% median: -6.92% win: 25% σ: 11.13% n: 4 2022-04-12 → 2026-05-29 | AVD Oct avg: -3.34% median: -7.84% win: 25% σ: 20.41% n: 4 2022-04-12 → 2026-05-29 | AVD Nov avg: 4.55% median: 2.23% win: 75% σ: 7.28% n: 4 2022-04-12 → 2026-05-29 | AVD Dec avg: -7.41% median: -11.82% win: 25% σ: 17.81% n: 4 2022-04-12 → 2026-05-29 |